However, despite similar coverage of tumor vessels by pericytes and increased ICAM-1 expression on tumor vascular endothelium, TCRTAG cell trafficking to the tumor bed differed among treated mice and was largely determined by the state of T-cell activation associated with heterogeneity of tumor-infiltrating myeloid cells and ECM remodeling. Here, ICAM1 is linked to neoplasm.